Natnaree Siriwon

1.3k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

Natnaree Siriwon is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Natnaree Siriwon has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Oncology. Recurrent topics in Natnaree Siriwon's work include CAR-T cell therapy research (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Natnaree Siriwon is often cited by papers focused on CAR-T cell therapy research (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Natnaree Siriwon collaborates with scholars based in United States, Thailand and China. Natnaree Siriwon's co-authors include Pin Wang, Kwang Gi Kim, Jennifer A. Rohrs, Elizabeth L. Siegler, Yarong Liu, Xiaolu Han, Si Li, John Mac, Xianhui Chen and Paul D. Bryson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and ACS Nano.

In The Last Decade

Natnaree Siriwon

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

2022 140 citations Moataz Reda, Worapol Ngamcherdtrakul et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natnaree Siriwon United States	13	593	403	400	327	156	15	1.0k
Elizabeth L. Siegler United States	14	910 1.5×	346 0.9×	444 1.1×	398 1.2×	198 1.3×	37	1.2k
Sepideh Izadi Iran	10	401 0.7×	240 0.6×	188 0.5×	228 0.7×	87 0.6×	20	686
Miryam Horovitz‐Fried Israel	8	531 0.9×	168 0.4×	184 0.5×	469 1.4×	109 0.7×	8	750
Marla Pyle United States	17	234 0.4×	377 0.9×	365 0.9×	108 0.3×	61 0.4×	32	1.1k
Marc Wehrli United States	12	363 0.6×	360 0.9×	109 0.3×	399 1.2×	100 0.6×	24	830
John Mac United States	7	384 0.6×	293 0.7×	175 0.4×	192 0.6×	91 0.6×	9	641
Myrofora Panagi Cyprus	15	312 0.5×	297 0.7×	297 0.7×	223 0.7×	23 0.1×	24	883
Eloah Rabello Suarez Brazil	10	375 0.6×	237 0.6×	186 0.5×	157 0.5×	98 0.6×	21	593
Ali Hassanzadeh Iran	7	360 0.6×	158 0.4×	140 0.3×	189 0.6×	87 0.6×	12	543
Justin H. Lo United States	13	256 0.4×	727 1.8×	230 0.6×	68 0.2×	95 0.6×	25	1.1k

Countries citing papers authored by Natnaree Siriwon

Since Specialization

Citations

This map shows the geographic impact of Natnaree Siriwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natnaree Siriwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natnaree Siriwon more than expected).

Fields of papers citing papers by Natnaree Siriwon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natnaree Siriwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natnaree Siriwon. The network helps show where Natnaree Siriwon may publish in the future.

Co-authorship network of co-authors of Natnaree Siriwon

This figure shows the co-authorship network connecting the top 25 collaborators of Natnaree Siriwon. A scholar is included among the top collaborators of Natnaree Siriwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natnaree Siriwon. Natnaree Siriwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lin, Yuan‐Chien, Xu Li, Yu-Chih Wu, et al.. (2025). The Bacterial Outer Membrane Vesicle-Cloaked Immunostimulatory Nanoplatform Reinvigorates T Cell Function and Reprograms Tumor Immunity. ACS Nano. 19(21). 19866–19889. 6 indexed citations

Ngamcherdtrakul, Worapol, Daniel S. Bejan, William Cruz‐Muñoz, et al.. (2022). Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis. Small. 18(11). e2107550–e2107550. 42 indexed citations

Reda, Moataz, Worapol Ngamcherdtrakul, Molly A. Nelson, et al.. (2022). Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nature Communications. 13(1). 4261–4261. 140 indexed citations breakdown →

Ngamcherdtrakul, Worapol, Daniel S. Bejan, William Cruz‐Muñoz, et al.. (2022). Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis (Small 11/2022). Small. 18(11). 1 indexed citations

Reda, Moataz, Worapol Ngamcherdtrakul, Shenda Gu, et al.. (2019). PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer. Cancer Letters. 467. 9–18. 56 indexed citations

Siriwon, Natnaree, Kwang Gi Kim, Elizabeth L. Siegler, et al.. (2018). CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction. Cancer Immunology Research. 6(7). 812–824. 143 indexed citations

Yantasee, Wassana, Glen E. Fryxell, Kanda Pattamakomsan, et al.. (2018). Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents. Journal of Hazardous Materials. 366. 677–683. 25 indexed citations

Liu, Yarong, et al.. (2018). Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature. Biotechnology and Bioengineering. 115(6). 1403–1415. 32 indexed citations

Li, Si, Natnaree Siriwon, Xiaoyang Zhang, et al.. (2017). Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor–Modified T Cells Engineered to Secrete Checkpoint Inhibitors. Clinical Cancer Research. 23(22). 6982–6992. 252 indexed citations

10.

Han, Xiaolu, Paul D. Bryson, Yifan Zhao, et al.. (2017). Masked Chimeric Antigen Receptor for Tumor-Specific Activation. Molecular Therapy. 25(1). 274–284. 93 indexed citations

11.

Siegler, Elizabeth L., Kwang Gi Kim, Xianhui Chen, et al.. (2017). Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers. Molecular Therapy. 25(12). 2607–2619. 88 indexed citations

12.

Kim, Kwang Gi, Elizabeth L. Siegler, Natnaree Siriwon, & Pin Wang. (2016). Therapeutic strategies for targeting cancer stem cells. Journal of Cancer Metastasis and Treatment. 2(7). 233–233. 31 indexed citations

13.

Liu, Yarong, Natnaree Siriwon, Jennifer A. Rohrs, & Pin Wang. (2015). Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy. Current Pharmaceutical Design. 21(22). 3248–3256. 14 indexed citations

14.

Cui, Miao, Natnaree Siriwon, Enhu Li, Eric H. Davidson, & Isabelle S. Peter. (2014). Specific functions of the Wnt signaling system in gene regulatory networks throughout the early sea urchin embryo. Proceedings of the National Academy of Sciences. 111(47). E5029–38. 63 indexed citations

15.

Liu, Yarong, Young Joo Kim, Man Ji, et al.. (2014). Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides. Molecular Therapy — Methods & Clinical Development. 1. 12–12. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact